Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Surgery in mesothelioma

Dr Paul Baas - Netherlands Cancer Institute, Amsterdam
Surgery in mesothelioma ( Dr Paul Baas - Netherlands Cancer Institute, Amsterdam )
16 May 2013

Advances and perspectives on biomarkers

Dr Nicola Normanno - Institute Fondazione Pascale, Naples, Italy
Advances and perspectives on biomarkers ( Dr Nicola Normanno - Institute Fondazione Pascale, Naples, Italy )
16 May 2013

Biomarker analyses in emerging data from PI3K/AKT/mTOR programme clinical trials

Dr Anna Vivancos - Vall d´Hebron Institute of Oncology, Barcelona, Spain
Biomarker analyses in emerging data from PI3K/AKT/mTOR programme clinical trials ( Dr Anna Vivancos - Vall d´Hebron Institute of Oncology, Barcelona, Spain )
16 May 2013

Integrating breast cancer genomics and proteomics

Dr Gordon Mills - University of Texas MD Anderson Cancer Center, Houston, USA
Integrating breast cancer genomics and proteomics ( Dr Gordon Mills - University of Texas MD Anderson Cancer Center, Houston, USA )
15 May 2013

Genetic and clinical factors best for predicting late recurrence in oestrogen receptor positive breast cancer

Dr Ivana Sestak - Queen Mary University of London, UK
Genetic and clinical factors best for predicting late recurrence in oestrogen receptor positive breast cancer ( Dr Ivana Sestak - Queen Mary University of London, UK )
15 May 2013

CD4 T cells in extensively inflitrated breast cancer signal organised immune response and predict survival

Dr Karen Willard-Gallo - Université Libre de Bruxelles, Brussels, Belgium
CD4  T cells in extensively inflitrated breast cancer signal organised immune response and predict survival ( Dr Karen Willard-Gallo - Université Libre de Bruxelles, Brussels, Belgium )
15 May 2013

How do we design trials that improve outcome?

Dr Lisa Carey - University of North Carolina, Chapel Hill, USA
How do we design trials that improve outcome? ( Dr Lisa Carey - University of North Carolina, Chapel Hill, USA )
15 May 2013

Breast cancer heterogeneity no barrier to predictive testing

Dr Michał Jarząb - Maria Skłodowska-Curie Institute of Oncology, Gliwice, Poland
Breast cancer heterogeneity no barrier to predictive testing ( Dr Michał Jarząb - Maria Skłodowska-Curie Institute of Oncology, Gliwice, Poland )
15 May 2013

Single cell sequencing techniques in early and late breast cancer

Dr Nicholas Navin - MD Anderson Cancer Center, Houston, TX, USA
Single cell sequencing techniques in early and late breast cancer ( Dr Nicholas Navin - MD Anderson Cancer Center, Houston, TX, USA )
15 May 2013

The future of PI3K/AKT/mTOR inhibitors in breast cancer

Dr Sara Hurvitz - UCLA Santa Monica Hematology Oncology, USA
The future of PI3K/AKT/mTOR inhibitors in breast cancer ( Dr Sara Hurvitz - UCLA Santa Monica Hematology Oncology, USA )
15 May 2013

Multitarget FISH testing in lung cancer

Dr Lucas Bubendorf – Institute for Pathology, University Hospital, Basel, Switzerland
Multitarget FISH testing in lung cancer ( Dr Lucas Bubendorf – Institute for Pathology, University Hospital, Basel, Switzerland )
15 May 2013

Mesothelioma and the tumour suppressor gene, NF2

Dr Emanuela Felley-Bosco – University Hospital Zurich, Switzerland
Mesothelioma and the tumour suppressor gene, NF2 ( Dr Emanuela Felley-Bosco – University Hospital Zurich, Switzerland )
15 May 2013